UPClytics
View all cases

UPC APP 58035/2024

Oct 24, 2024·EP4201327 +1 more: FLUID DELIVERY DEVICE WITH TRANSCUTANEOUS ACCESS TOOL, INSERTION MECHANISM AND BLOOD GLUCOSE MONITORING FOR USE THEREWITH

Case details
Status
Written Phase
Action
Generic
Category
Costs Assessments
Parties
Claimants
Reps: Marc Grunwald
Respondents
Reps: Martin Kohler
Division
Milan LD
Technology
Packaging & Conveying
Language
English
First decided
Dec 30, 2024
Decisions
  • 2024-12-30
    DismissedCostsGeneric application

    Milan Local Division dismissed Insulet Corporation's application for a cost decision following the rejection of EOFLOW Co. Ltd.'s intervention request in PI proceedings (EP 4 201 327). The court found the application inadmissible: a cost decision under R. 150 RoP requires a prior decision on costs in principle under R. 118.5 RoP. The order rejecting the intervention (1 October 2024) contained no such costs-in-principle decision, so the cost-determination application lacked the prerequisite under R. 156(e) RoP. Insulet was invited to resubmit once a costs award decision was obtained.

    Legal issues:Prerequisite of costs-in-principle decision for cost determination application (R. 150, 156 RoP)Cost decision following rejection of intervention request
Documents
Document titleDatePublic
Headnote-and-Keywords2025-01-08Not public
Outcome of the Order2024-12-30Not public
finale order 30 December 20242024-12-30Public
rule 152 ROP2024-11-11Not public
Receipt2024-10-24Not public
Application for Cost Decision2024-10-24Not public
Exhibit PS-C012024-10-24Not public
Insulet Corporation v A. Menarini Diagnostics s.r.l. — UPC APP 58035/2024 | UPClytics